197 related articles for article (PubMed ID: 31668889)
1. Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018.
Kong CL; Thompson RR; Porco TC; Kim E; Acharya NR
Ophthalmology; 2020 Mar; 127(3):324-330. PubMed ID: 31668889
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the Recombinant Zoster Vaccine for Herpes Zoster Ophthalmicus in the United States.
Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
Ophthalmology; 2021 Dec; 128(12):1699-1707. PubMed ID: 33892049
[TBL] [Abstract][Full Text] [Related]
3. Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study.
Borkar DS; Tham VM; Esterberg E; Ray KJ; Vinoya AC; Parker JV; Uchida A; Acharya NR
Ophthalmology; 2013 Mar; 120(3):451-456. PubMed ID: 23207173
[TBL] [Abstract][Full Text] [Related]
4. Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination.
Walia A; Sun Y; Acharya NR
JAMA Ophthalmol; 2024 Mar; 142(3):249-256. PubMed ID: 38358762
[TBL] [Abstract][Full Text] [Related]
5. Seasonality of herpes zoster and herpes zoster ophthalmicus.
Berlinberg EJ; Kim E; Deiner MS; Patterson C; Porco TC; Acharya NR
J Clin Virol; 2020 May; 126():104306. PubMed ID: 32151977
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster ophthalmicus: frequency and risk factors for developing uncommon ocular manifestations.
Dmitriev AA; Odden J; Mora-Boellstorff D; Kinchington PR; Sheridan K; Viehman JA; Price D; Koscumb S; Marroquin O; Sahel JA; Kowalski RP; Jhanji V; Errera MH
Can J Ophthalmol; 2024 Jun; 59(3):201-207. PubMed ID: 37192736
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster ophthalmicus: comparison of disease in patients 60 years and older versus younger than 60 years.
Ghaznawi N; Virdi A; Dayan A; Hammersmith KM; Rapuano CJ; Laibson PR; Cohen EJ
Ophthalmology; 2011 Nov; 118(11):2242-50. PubMed ID: 21788078
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity.
Tran KD; Falcone MM; Choi DS; Goldhardt R; Karp CL; Davis JL; Galor A
Ophthalmology; 2016 Jul; 123(7):1469-75. PubMed ID: 27067924
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
Sun Y; Jackson K; Dalmon CA; Shapiro BL; Nie S; Wong C; Arnold BF; Porco TC; Acharya NR
Vaccine; 2021 Jun; 39(29):3974-3982. PubMed ID: 34116874
[TBL] [Abstract][Full Text] [Related]
10. Herpes zoster ophthalmicus: declining age at presentation.
Davies EC; Pavan-Langston D; Chodosh J
Br J Ophthalmol; 2016 Mar; 100(3):312-4. PubMed ID: 26178905
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex and herpes zoster eye disease: presentation and management at a city hospital for the underserved in the United States.
Edell AR; Cohen EJ
Eye Contact Lens; 2013 Jul; 39(4):311-4. PubMed ID: 23771014
[TBL] [Abstract][Full Text] [Related]
12. Using natural language processing for identification of herpes zoster ophthalmicus cases to support population-based study.
Zheng C; Luo Y; Mercado C; Sy L; Jacobsen SJ; Ackerson B; Lewin B; Tseng HF
Clin Exp Ophthalmol; 2019 Jan; 47(1):7-14. PubMed ID: 29920898
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with age of onset of herpes zoster ophthalmicus.
Chan AY; Conrady CD; Ding K; Dvorak JD; Stone DU
Cornea; 2015 May; 34(5):535-40. PubMed ID: 25710509
[TBL] [Abstract][Full Text] [Related]
14. Annual incidence rates of herpes zoster among an immunocompetent population in the United States.
Johnson BH; Palmer L; Gatwood J; Lenhart G; Kawai K; Acosta CJ
BMC Infect Dis; 2015 Nov; 15():502. PubMed ID: 26546419
[TBL] [Abstract][Full Text] [Related]
15. Herpetic Eye Disease After SARS-CoV-2 Vaccination: A CDC-VAERS Database Analysis.
Singh RB; Parmar UPS; Ichhpujani P; Jeng BH; Jhanji V
Cornea; 2023 Jun; 42(6):731-738. PubMed ID: 36706232
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study.
Lin HC; Chien CW; Ho JD
Neurology; 2010 Mar; 74(10):792-7. PubMed ID: 20200348
[TBL] [Abstract][Full Text] [Related]
17. Increasing Rates of Herpes Zoster Ophthalmicus and the COVID-19 Pandemic.
Snyder AJ; Mousa HM; Soifer M; Jammal AA; Aggarwal S; Perez VL
Res Sq; 2023 May; ():. PubMed ID: 37215036
[TBL] [Abstract][Full Text] [Related]
18. Practice Patterns in the Initial Management of Herpes Zoster Ophthalmicus in the United States.
Lu A; Sun Y; Porco TC; Arnold BF; Acharya NR
Cornea; 2024 Jan; 43(1):6-12. PubMed ID: 36952627
[TBL] [Abstract][Full Text] [Related]
19. Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Loss of Vision.
Niederer RL; Meyer JJ; Liu K; Danesh-Meyer HV
Am J Ophthalmol; 2021 Jun; 226():83-89. PubMed ID: 33571476
[TBL] [Abstract][Full Text] [Related]
20. Text-Based Identification of Herpes Zoster Ophthalmicus With Ocular Involvement in the Electronic Health Record: A Population-Based Study.
Zheng C; Sy LS; Tanenbaum H; Tian Y; Luo Y; Ackerson B; Tseng HF
Open Forum Infect Dis; 2021 Feb; 8(2):ofaa652. PubMed ID: 33575426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
